US Patent 7696161 Exendin agonist compounds

Patent 7696161 was granted and assigned to Amylin Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amylin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7696161

Date of Patent

April 13, 2010

Patent Application Number

11807031

Date Filed

May 25, 2007

Patent Citations Received

‌

US Patent 11884713 Acylated glucagon analogues

Patent Primary Examiner

‌

Anand U Desai

Patent abstract

Novel exendin agonist compounds are provided. These compounds are useful in treating diabetes and conditions which would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7696161 Exendin agonist compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API